Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study (Q28254377)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study	scientific article

Statements

scholarly article

0 references

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study (English)

0 references

0 references

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

Richard Weisler

1

0 references

Mark Joyce

2

0 references

Lora McGill

3

0 references

Arthur Lazarus

4

0 references

Johan Szamosi

5

0 references

Hans Eriksson

6

0 references

language of work or name

0 references

publication date

June 2009

0 references

C N S Spectrums

0 references

14

0 references

6

0 references

299-313

0 references

Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Sleep problems and suicidality in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Antidepressants and the risk of suicidal behaviors

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Paroxetine: an update of its use in psychiatric disorders in adults

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Inverse association between physical inactivity and mental health in men and women.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

No health without mental health

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

21 January 2018

Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

7 January 2021

based on heuristic

inferred from DOI database lookup

Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopharmacology: number needed to treat: an underused measure of treatment effect

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

7 January 2021

based on heuristic

inferred from DOI database lookup

Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900020307

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1092852900020307

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

release_3bpy72bkgfc2thjazox2hnkzki

1 reference

https://api.fatcat.wiki/v0/release/3bpy72bkgfc2thjazox2hnkzki

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28254377&oldid=1976140822"